What states will Cizzle Biotechnology Holdings deploy its North American laboratory roll‑out across?

Cizzle Biotechnology Holdings plans to deploy its North American laboratory roll‑out across New York, California, South Carolina, Tennessee and Florida, with the aim of achieving nationwide US coverage.

Cizzle Biotechnology

Timeline

Cizzle's US partner adds second lab for lung cancer test

15:01, 3 Aug 2026

Health & Bio Today: Cizzle wins US lab accreditation for lung cancer test, CelLBxHealth, EDX Medical

17:02, 15 Jul 2026

Cizzle Biotechnology gains US accreditation for lung cancer test

09:41, 15 Jul 2026

Health & Bio Today: BSF Enterprise, Cizzle Biotechnology, Poolbeg Pharma, Istesso, Inspiration Healthcare

17:04, 16 Jun 2026

Cizzle Biotechnology Holdings shares skyrocketed after US CLIA approval

08:26, 16 Jun 2026 · Updated 16:30, 16 Jun

Health & Bio Today: BSF Enterprise shares halve after T-Rex handbag fails at auction, Cizzle Biotechnology, GSK

17:05, 12 Jun 2026

Cizzle Biotechnology Holdings shares up on US patent grant

07:49, 12 Jun 2026 · Updated 13:59, 12 Jun

More in Telecoms

Telecoms

Vodafone completes VodafoneZiggo sale to Liberty Global

Vodafone has sold its stake in VodafoneZiggo for €1bn in cash plus a 10% shareholding in an enlarged Ziggo Group, with proceeds earmarked for debt reduction.

15:04, 3 Aug 2026

Telecoms

Helios Towers upgrades 2026 guidance after record tenancy growth

08:41, 30 Jul 2026

Renewables & Clean Energy

The Morning Brief: BAE Systems, Haleon, Lloyds, Hammerson, LSEG, Shell, Drax, Segro, Anglo American

08:02, 30 Jul 2026

Pharma

Haleon lifts interim dividend 9% as margins expand

07:36, 30 Jul 2026

Telecoms

Deutsche Bank keeps Vodafone at Buy after first-quarter beat

18:33, 28 Jul 2026

Telecoms

Vodafone Group shares surge after FY27 guidance lift

Updated 13:48, 28 Jul 2026

Telecoms

Tech Today: Shearwater Group upgrades FY26 outlook, Quartix Technologies, Vodafone, Dianomi, Quantum Blockchain Technologies, Pathos Communications

17:02, 27 Jul 2026

Software & SaaS

Tech Today: Videndum slashes guidance and names new chief, StarEdge, Auction Technology Group, Spectra Systems, SRT Marine, BT Group, Getech, Metir, Smarter Web Company, Google

17:04, 23 Jul 2026

Telecoms

BT holds course on full-year targets after solid first quarter

Updated 13:07, 23 Jul 2026

Food & Beverage

The Premarket Brief: Frasers extends Accent Group offer, Mitchells & Butlers, Anglo American, BT Group, easyJet, Centrica, AstraZeneca, AJ Bell

08:00, 23 Jul 2026

Software & SaaS

Tech Today: Insig AI backs Belgian micropayments start-up 4Mica, MedPal AI

17:02, 20 Jul 2026

Cizzle Biotechnology Holdings is a UK-based molecular diagnostics company developing blood-based cancer detection tests using proprietary technology to identify circulating tumor DNA and proteins. The company operates in the early-stage oncology diagnostics market, with a focus on commercializing its lead test for early cancer detection across multiple cancer types. As a small-cap listed on the London Stock Exchange, Cizzle remains in the clinical validation and commercialization phase with limited revenue generation to date.

Sector: Telecoms
Market: MAINMARKET

Insight

What US accreditation does Cizzle Biotechnology have for its lung cancer test?

Cizzle Biotechnology has US laboratory accreditation for its lung cancer test.

Updated 16 Jul 2026

Insight

When did Cizzle complete its statutory reporting for the year ended 31 December 2025?

Cizzle completed its statutory reporting for the year ended 31 December 2025 (the reporting was completed for that year).

Updated 15 Jul 2026

Insight

Which patents were recently granted that Cizzle Biotechnology Holdings says reinforce its IP protection in North America?

Cizzle Biotechnology Holdings reported that recent United States and Canadian patent grants reinforce its intellectual property protection in its two most important North American markets.

Updated 15 Jul 2026

Insight

How much are the aggregate guaranteed minimum royalty receipts under Cizzle Biotechnology Holdings' BIO agreement?

Aggregate guaranteed minimum royalty receipts under Cizzle Biotechnology Holdings' Cizzle Bio (BIO) agreement have risen to approximately $5.9 million.

Updated 16 Jul 2026

Insight

In which countries did Cizzle secure patent protection for its two‑step ELISA test format and related capture‑agent methods during the first half of 2026?

During the first half of 2026 Cizzle secured patent protection for its two‑step ELISA test format and related capture‑agent methods in Canada and the United States.

Updated 15 Jul 2026

Identifiers

Ticker: LSE:CIZ
Market: MAINMARKET
ISIN: GB00BNG2VN02
LEI: 213800G3OS3SA2J1Y358

Learn more on:

GLEIF Companies House

Timeline

Cizzle's US partner adds second lab for lung cancer test

Health & Bio Today: Cizzle wins US lab accreditation for lung cancer test, CelLBxHealth, EDX Medical

Cizzle Biotechnology gains US accreditation for lung cancer test

Health & Bio Today: BSF Enterprise, Cizzle Biotechnology, Poolbeg Pharma, Istesso, Inspiration Healthcare

Cizzle Biotechnology Holdings shares skyrocketed after US CLIA approval

Health & Bio Today: BSF Enterprise shares halve after T-Rex handbag fails at auction, Cizzle Biotechnology, GSK

Cizzle Biotechnology Holdings shares up on US patent grant

More in Telecoms

Vodafone completes VodafoneZiggo sale to Liberty Global

Helios Towers upgrades 2026 guidance after record tenancy growth

The Morning Brief: BAE Systems, Haleon, Lloyds, Hammerson, LSEG, Shell, Drax, Segro, Anglo American

Haleon lifts interim dividend 9% as margins expand

Deutsche Bank keeps Vodafone at Buy after first-quarter beat

Vodafone Group shares surge after FY27 guidance lift

Tech Today: Shearwater Group upgrades FY26 outlook, Quartix Technologies, Vodafone, Dianomi, Quantum Blockchain Technologies, Pathos Communications

Tech Today: Videndum slashes guidance and names new chief, StarEdge, Auction Technology Group, Spectra Systems, SRT Marine, BT Group, Getech, Metir, Smarter Web Company, Google

BT holds course on full-year targets after solid first quarter

The Premarket Brief: Frasers extends Accent Group offer, Mitchells & Butlers, Anglo American, BT Group, easyJet, Centrica, AstraZeneca, AJ Bell

Tech Today: Insig AI backs Belgian micropayments start-up 4Mica, MedPal AI

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer